Abbott Laboratories has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Looking back on health insurance providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Progyny (NASDAQ:PGNY) and its peers. Upfront premiums collected ...

Equity REITs logged a slump in their average Q1 FFO per share amid a decline in occupancy rates, the latest T-Tracker report by Nareit showed. Aggregate FFO was down 7.60% from Q4 2024 but up 2.91 ...

Cigna Group's CI -0.26% + Free Alerts short percent of float has fallen 14.19% since its last report. The company recently ...

Asana raised its fiscal 2026 adjusted EPS guidance from a range of 19 cents to 20 cents to 22 cents, versus the 33 cent ...

Cigna’s earnings beat Wall Street expectations, providing relief to investors who had soured on the struggles of insurers’ Medicare and Medicaid businesses. The company, parent of a health ...

As a reminder, analyst estimates came down quite a bit after the company provided weak Q1 guidance back at its Q4 2024 report. In the end, NIO reported revenues that came in a little under $1.66 ...

Nvidia’s earnings have become ... the innovative chip giant will report its fiscal first-quarter results for 2025, and expectations are once again high. Analysts expect Q1 revenue to grow ...

Customers weren't the only ones getting blowouts from Ulta Beauty Inc. (NASDAQ: ULTA) last week, as the company blew away expectations in its Q1 2025 earnings report, released Thursday after the ...